- Worked in the Global Product Strategy group to develop insights across the Ophthalmology franchise, covering two Phase III assets in DME and nAMD, along with a variety of earlier stage molecules across indications- Informing strategy through management of primary market research, secondary analytics and forecasting in a global environment, collaborating with cross-functional stakeholders in GPS and within country affiliates

- Worked within global oncology marketing to develop insights for Blincyto, covering marketed indications (across Leukemia) and developing ones (in Lymphoma), with additional support for early assets in Multiple Myeloma- Management of primary market research and secondary analytics, in addition to collaborating on cross-functional brand team activities and departmental initiatives

Responsible for development of an array of insights that form the foundation of product strategy for Lampalizumab, an early Phase III compound in Roche's I2O (Immunology, Infectious Diseases and Ophthalmology) Franchise.

Creation of actionable insights and recommendations within the global Skin Oncology franchise, through conduct of primary market research, forecasting, and analytics

Representing the voice of the customer to the CNS franchise, managing qualitative and quantitative market research for brands in development for Schizophrenia and Bipolar Disorder

Responsible for maintaining project timelines, client communication, preparation and deliveryof presentations and other project deliverables. Continued project work in forecasting, market research, segmentation, and targeting, across therapeutic areas.

Project experience in market analytics, customer segmentation, forecasting, quantitative market research and conjoint design.

Recipient of an NSF funded fellowship to foster research collaboration between Stanford and Tsinghua Universities, conducting a cross-cultural experiment on Human Robot InteractionResponsible for survey design, conduct of short qualitative interviews, subject observation